Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

BBI Solutions to Finalize Development of CDC Anthrax Diagnostic

by Global Biodefense Staff
August 16, 2015
Anthrax Bacteria - Bacillus Anthracis

Anthrax Bacteria - Bacillus Anthracis

The Centers for Disease Control and Prevention (CDC) has announced intentions to issue a sole source contract to BBI Solutions to support optimization of an anthrax toxin diagnostic.

The purpose of this procurement is to advance a lateral flow device diagnostic for anthrax toxin lethal factor from early prototype stage to a device ready for validation. BBI Solutions will optimize the diagnostic to enhance sensitivity, finalize design, define performance characteristics, and prepare for clinical validation.

“Our laboratory scientists provide unique subject matter expertise in B. anthracis microbiology, pathogenicity, and in the prevention, diagnosis and treatment of anthrax,” states the contract announcement. “This procurement will advance our current device from early prototype to a device ready for validation.”

This contract will provide the necessary enhancements to advance the device from prototype to validation-ready device, including activities to:

  • Maximize sensitivity of the devices
  • Identify quality control panel for evaluation of devices
  • Establish final cartridge design
  • Establish data collection and interpretation methods
  • Obtain performance data on assay

Devices from this project are expected to result in a late stage product ready for clinical validation and testing. Data generated will be available for inclusion in an FDA 510(k) submission package.

Source: FBO.gov

Tags: AnthraxAwardsBioterrorismPOC Diagnostics

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC